Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLPE) were isolated from clinical specimens from 130 to 140 patients/year in 1989-1991 in our hospital. In February 1992, a control program was initiated: screening tests in 3 intensive care units (ICUs) and contact-isolation precautions in all units. The septic surgical unit served as an isolation ward for surgical patients from whom ESBLPE was isolated. In 1992, the incidence of ESBLPE acquisition failed to decrease, and most acquisitions occurred in 3 ICUs. Critical evaluation of implementation of isolation procedures in these ICUs prompted corrective measures for barrier precautions. The incidence of acquired cases subsequently decreased, and a second evaluation determined that these measures had been correctly applied. The incidence of acquired cases in the septic surgical unit was lower than those in the other units. Decreases were also found in the incidence of acquisition of other hand-transmitted multidrug-resistant organisms. Barrier precautions, screening tests for ICU patients, and grouping of cohorts after ICU discharge are effective in controlling the spread of multidrug-resistant microorganisms by cross-contamination. The outbreak was effectively controlled without restricting antimicrobial use.

[1]  T. Pitt,et al.  Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. , 1995, The Journal of hospital infection.

[2]  F. Baquero,et al.  New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak , 1995, Antimicrobial agents and chemotherapy.

[3]  K S Meyer,et al.  Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins , 1993, Annals of Internal Medicine.

[4]  D. Livermore,et al.  Survey of the prevalence of beta-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. , 1992, The Journal of antimicrobial chemotherapy.

[5]  L. Nicolle,et al.  Klebsiella pneumoniae infection on a rehabilitation unit: comparison of epidemiologic typing methods. , 1993 .

[6]  R. George,et al.  Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime. , 1992, The Journal of hospital infection.

[7]  W. L. Wang,et al.  Nosocomial klebsiella infections: intestinal colonization as a reservoir. , 1971, Annals of internal medicine.

[8]  E. Larson,et al.  Compliance with handwashing and barrier precautions. , 1995, The Journal of hospital infection.

[9]  M. Struelens,et al.  Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae , 1996, Journal of clinical microbiology.

[10]  J. Garner.  Guideline for isolation precautions in hospitals. , 1996 .

[11]  V. Jarlier,et al.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. , 1988, Reviews of infectious diseases.

[12]  R. Gaynes,et al.  Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System. , 1997, Infection control and hospital epidemiology.

[13]  J. Chastre,et al.  Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. , 1988, The American journal of medicine.

[14]  P. Desjardins,et al.  Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital , 1993, Journal of clinical microbiology.

[15]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[16]  F. Barbut,et al.  Decreased transmission of Enterobacteriaceae with extended-spectrum beta-lactamases in an intensive care unit by nursing reorganization. , 1995, The Journal of hospital infection.

[17]  M. Tymms,et al.  Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae , 1995, Journal of clinical microbiology.

[18]  R. Gaynes,et al.  Evidence of Interhospital Transmission of Extended-Spectrum β-Lactam-Resistant Klebsiella pneumoniae in the United States, 1986 to 1993 , 1997, Infection Control & Hospital Epidemiology.

[19]  J. Ariza,et al.  Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. , 1997, The Journal of hospital infection.

[20]  Patrick Legrand,et al.  TRANSFERABLE ENZYMATIC RESISTANCE TO THIRD-GENERATION CEPHALOSPORINS DURING NOSOCOMIAL OUTBREAK OF MULTIRESISTANT KLEBSIELLA PNEUMONIAE , 1987, The Lancet.

[21]  B. Wiedemann,et al.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins , 1985, Antimicrobial Agents and Chemotherapy.

[22]  H. Humphreys,et al.  Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. , 1998, The Journal of hospital infection.

[23]  J. Heritage,et al.  Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. , 1997, The Journal of antimicrobial chemotherapy.

[24]  R. Haley,et al.  Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. , 1995, The Journal of infectious diseases.

[25]  S. Cohen,et al.  The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  V L Yu,et al.  Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. , 1991, Annals of internal medicine.

[27]  C. Soussy,et al.  Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France , 1992, Antimicrobial Agents and Chemotherapy.

[28]  J. Ariza,et al.  Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases , 1998, Antimicrobial Agents and Chemotherapy.

[29]  S. B. Singer,et al.  Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients , 1992, Antimicrobial Agents and Chemotherapy.

[30]  J Sirot,et al.  Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit , 1989, Journal of clinical microbiology.

[31]  S. Chevret,et al.  Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  G. Bourg,et al.  Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital , 1994, Journal of clinical microbiology.

[33]  R. Bartlett,et al.  Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. , 1982, The Journal of trauma.

[34]  M. Gilchrist,et al.  Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.

[35]  J. Lucet,et al.  Clinical and bacteriologic epidemiology of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit , 1998 .

[36]  Garner Js.  Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee , 1996 .

[37]  R. Hobson,et al.  An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. , 1996, The Journal of hospital infection.

[38]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[39]  I. Phillips,et al.  Hands as route of transmission for Klebsiella species. , 1977, British medical journal.

[40]  A. Philippon,et al.  Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. , 1988, The Journal of antimicrobial chemotherapy.

[41]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[42]  D. Horn,et al.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.

[43]  F Lemaire,et al.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. , 1989, Annals of internal medicine.

[44]  G. Papanicolaou,et al.  Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility , 1990, Antimicrobial Agents and Chemotherapy.

[45]  P. Lagrange,et al.  Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals , 1994, Journal of clinical microbiology.

[46]  M Rapin,et al.  Diagnosis of Central Venous Catheter-Related Sepsis: Critical Level of Quantitative Tip Cultures , 1987 .

[47]  J. Rickman,et al.  Guilt and dynamics of psychological disorder. , 1948, Lancet.